Journal of Commercial Biotechnology
Abbreviated title (ISO 4) | J Commerc Biotechnol |
|---|---|
| Discipline | Biotechnology |
| Language | English |
| Publication details | |
| Publisher | |
Publication history | 1992 to present |
| Indexing | |
| ISSN |
1462-8732 (print) 1478-565X (web) |
| Links | |
The Journal of Commercial Biotechnology (J Commerc Biotechnol; ISSN 1462-8732) is a peer-reviewed academic journal covering the business of biotechnology. Topics covered include biotechnology management, policy, finance, law, and regulations.
The Journal of Commercial Biotechnology was founded by Henry Stewart Publications in 1992 as the Journal of Biotechnology in Healthcare,[1] and changed its name to the Journal of Commercial Biotechnology in 1998.[2] The journal was later published by Palgrave MacMillan[3] and was purchased by thinkBiotech[4] in 2010. It is published quarterly. An external Editorial Board assists with peer review. The current editor of the Journal of Commercial Biotechnology is Yali Friedman, who has served since 2007.
External links
References
This article is issued from Wikipedia - version of the 1/11/2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.